Related Experiment Video

Updated: Mar 7, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

10.3K

Recombinant Poxvirus and the Tumor Microenvironment: Oncolysis, Immune Regulation and Immunization

Daniel W Sharp1, Edmund C Lattime2

  • 1Rutgers Robert Wood Johnson Medical School, Rutgers, The State University of New Jersey, New Brunswick, NJ 08903-2681, USA; sharpdw@cinj.rutgers.edu.

Biomedicines
|February 14, 2017
PubMed

Insights

Oncolytic viruses (OVs) are engineered to fight cancer by directly killing tumor cells and stimulating the immune system. Expressing tumor antigens turns these viruses into vaccines, enhancing anti-cancer immune responses.

Area of Science:

  • Oncolytic virology
  • Cancer immunotherapy
  • Vaccine development

Background:

  • Oncolytic viruses (OVs) are explored for cancer therapy due to direct tumor cell lysis.
  • OVs can also induce systemic antitumor immunity by releasing tumor antigens and immunostimulatory molecules.
  • This dual action positions OVs as a versatile platform for immunotherapeutic strategies.

Purpose of the Study:

  • To investigate the potential of engineering oncolytic viruses to express tumor-associated antigens (TAAs).
  • To evaluate the efficacy of these engineered viruses as therapeutic vaccines.
  • To assess the modulation of the tumor microenvironment and immune responses.

Main Methods:

  • Engineering poxviruses to express TAAs and immune stimulatory molecules.
  • Intratumoral vaccination in preclinical models.
  • Analysis of tumor microenvironment modulation and immune cell activity.

Main Results:

  • Intratumoral vaccination with engineered poxviruses modulated the tumor microenvironment.
  • Engineered OVs overcame immune inhibitory pathways within the tumor.
  • Local and systemic tumor-specific immune responses were significantly enhanced.

Conclusions:

  • Engineering oncolytic viruses to express TAAs creates potent therapeutic vaccines.
  • This approach effectively drives antitumor immunity, complementing direct oncolytic effects.
  • OVs represent a promising strategy for enhancing cancer immunotherapy outcomes.
Keywords:
GM-CSF (granulocyte-macrophage colony-stimulating factor)TRICOM (triad of costimulatory molecules)immunotherapyoncolytic virusespoxvirustumor microenvironmentvaccinia

More Related Videos

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

4.1K
A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors09:16

A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors

Published on: October 30, 2016

11.9K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.2K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.0K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.7K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.5K